Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;63(6):378-82.
doi: 10.1007/s13224-013-0422-2. Epub 2013 Jul 12.

Routine Screening for Rubella and CMV Antibodies During Pregnancy: Is it Justifiable?

Anita Chakravarti  1 , Abha Sharma  1 , Monika Matlani  1
Affiliations

Routine Screening for Rubella and CMV Antibodies During Pregnancy: Is it Justifiable?

Anita Chakravarti et al. J Obstet Gynaecol India. 2013 Dec.

Abstract

Background: Rubella and cytomegalovirus (CMV) screening during pregnancy is routinely carried out in India. However, its value has been questioned due to the absence of clearly effective intervention.

Objectives: This retrospective study evaluates the usefulness of rubella and CMV antibody screening during pregnancy.

Materials and methods: Serum samples received from pregnant women and children were tested for rubella- and CMV-specific IgM antibodies by capture ELISA. The data were analyzed to determine the incidence of rubella and CMV infection during pregnancy and in congenital infections.

Results: In asymptomatic pregnant females (n = 505), rubella positivity was 3.16 % and in women with bad obstetric history (BOH) (n = 220), it was 7.72 %, while CMV positivity was 5.9 % in both asymptomatic pregnant women and in women with BOH. In children (n = 200), the overall positivity for rubella- and CMV-specific IgM antibodies was 15 and 25 %, respectively. A declining trend was observed in the incidence of both rubella and CMV infections in pregnant women and in women with BOH. In children, the incidence of congenital rubella syndrome has declined, but the incidence of CMV infection has remained almost the same in 5 years.

Conclusion: The incidence of rubella has reduced over the past 5 years and can further be prevented by providing direct protection to women and school girls with rubella vaccines. Primary CMV infection in pregnancy is the main problem, and due to the unavailability of efficient and safe treatment, routine antenatal screening for rubella and CMV should be reserved for women with obstetric complications only.

Keywords: Pregnant women; Routine screening; Rubella and CMV antibodies.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Annually reported cases of rubella and CMV in pregnant women
Fig. 2
Fig. 2
Annually reported cases of rubella and CMV in children
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Epps RE, Pittelknow MR, Su WP. TORCH Syndrome Semin Dermatol. 1995;14:179. doi: 10.1016/S1085-5629(05)80016-1. - DOI - PubMed
    1. Singh MP, Arora S, Das A, et al. Congenital rubella and cytomegalovirus infections in and around Chandigarh. Ind J Pathol Microbiol. 2009;52(1):46–48. doi: 10.4103/0377-4929.44962. - DOI - PubMed
    1. Cutts FT, Robertson SE, Diaz-Ortega JL, et al. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 1: burden of diseases from CRS. Bull World Health Organ. 1997;75:55–68. - PMC - PubMed
    1. Khan NA, Kazzi SN. Yield and costs of screening growth-retarded infants for TORCH infections. Am J Perinatal. 2000;17:131. doi: 10.1055/s-2000-9288. - DOI - PubMed
    1. Cullen A, Brown S, Cafferkey M, et al. Current use of the TORCH screen in the diagnosis of congenital infection. J Infect. 1998;36:185. doi: 10.1016/S0163-4453(98)80011-X. - DOI - PubMed

LinkOut - more resources